hypomagnesemia in chronic kidney disease: problem or individual characteristics of certain patients?
Clicks: 191
ID: 203931
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
191 views
32 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #30 of 39 articles by views in oncology letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The article considers the problem of magnesium deficiency in patients with chronic kidney disease. It requires special attention from clinicians due to the increased risk of cardiovascular complications. The study revealed that one third of patients with chronic kidney disease stages I–III has a magnesium deficiency. The use of magnesium preparations helps to normalize the magnesium homeostasis.
| Reference Key |
savytska2016pokihypomagnesemia
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;L.M. Savytska |
| Journal | oncology letters |
| Year | 2016 |
| DOI |
10.22141/2307-1257.3.17.2016.76455
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.